Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19
Authors: Augusto João B , Menacho Katia , Andiapen Mervyn , Bowles Ruth , Burton Maudrian , Welch Sophie , Bhuva Anish N , Seraphim Andreas , Pade Corinna , Joy George , Jensen Melanie , Davies Rhodri H , Captur Gabriella , Fontana Marianna , Montgomery Hugh , O’Brien Ben , Hingorani Aroon D , Cutino-Moguel Teresa , McKnight Áine , Abbass Hakam , Alfarih Mashael , Alldis Zoe , Baca Georgina L , Boulter Alex , Bracken Olivia V , Bullock Natalie , Champion Nicola , Chan Carmen , Couto-Parada Xose , Dieobi-Anene Keenan , Feehan Karen , Figtree Gemma , Figtree Melanie C , Finlay Malcolm , Forooghi Nasim , Gibbons Joseph M , Griffiths Peter , Hamblin Matt , Howes Lee , Itua Ivie , Jones Meleri , Jardim Victor , Kapil Vikas , Jason Lee Wing-Yiu , Mandadapu Vineela , Mfuko Celina , Mitchelmore Oliver , Palma Susana , Patel Kush , Petersen Steffen E , Piniera Brian , Raine Rosalind , Rapala Alicja , Richards Amy , Sambile Genine , Couto de Sousa Jorge , Sugimoto Michelle , Thornton George D , Artico Jessica , Zahedi Dan , Parker Ruth , Robathan Mathew , Hickling Lauren M , Ntusi Ntobeko , Semper Amanda , Brooks Tim , Jones Jessica , Tucker Art , Veerapen Jessry , Vijayakumar Mohit , Wodehouse Theresa , Wynne Lucinda , Treibel Thomas A , Noursadeghi Mahdad , Manisty Charlotte , Moon James C 
Published: October 2020

Background: Most biomedical research has focused on sampling COVID-19 patients presenting to hospital with advanced disease, with less focus on the asymptomatic or paucisymptomatic. We established a bioresource with serial sampling of health care workers (HCWs) designed to obtain samples before and during mainly mild disease, with follow-up sampling to evaluate the quality and duration of immune memory.

Methods: We conducted a prospective study on HCWs from three hospital sites in London, initially at a single centre (recruited just prior to first peak community transmission in London), but then extended to multiple sites 3 weeks later (recruitment still ongoing, target n=1,000). Asymptomatic participants attending work complete a health questionnaire, and provide a nasal swab (for SARS-CoV-2 RNA by RT-PCR tests) and blood samples (mononuclear cells, serum, plasma, RNA and DNA are biobanked) at 16 weekly study visits, and at 6 and 12 months.

Results: Preliminary baseline results for the first 731 HCWs (400 single-centre, 331 multicentre extension) are presented. Mean age was 38±11 years; 67% are female, 31% nurses, 20% doctors, and 19% work in intensive care units. COVID-19-associated risk factors were: 37% black, Asian or minority ethnicities; 18% smokers; 13% obesity; 11% asthma; 7% hypertension and 2% diabetes mellitus. At baseline, 41% reported symptoms in the preceding 2 weeks. Preliminary test results from the initial cohort (n=400) are available: PCR at baseline for SARS-CoV-2 was positive in 28 of 396 (7.1%, 95% CI 4.9-10.0%) and 15 of 385 (3.9%, 2.4-6.3%) had circulating IgG antibodies.

Conclusions: This COVID-19 bioresource established just before the peak of infections in the UK will provide longitudinal assessments of incident infection and immune responses in HCWs through the natural time course of disease and convalescence. The samples and data from this bioresource are available to academic collaborators by application https://covid-consortium.com/application-for-samples/.